US Patent Issued to MONASH UNIVERSITY, PETER MACCALLUM CANCER INSTITUTE on Sept. 29 for "Methods of activating cells via PTP 1B inhibition" (Australian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,285, issued on Sept. 29, was assigned to MONASH UNIVERSITY (Clayton, Australia) and PETER MACCALLUM CANCER INSTITUTE (Melbournd, Australia).

"Methods of activating cells via PTP 1B inhibition" was invented by Tony Tiganis (Clayton, Australia) and Florian Wiede (Clayton, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention generally relates to methods of activating cells for use in therapy. For example, the invention relates to preparing cells ex vivo for use in immunotherapy, particularly cancer immunotherapy. More specifically, the invention relates to methods for the preparation of leukocytes, particularly T cells throug...